Archive for September 2021
Drivers group supports bill giving Uber, Lyft drivers power to bargain
The bargaining bill is another facet of the debate over the rights of Uber and Lyft drivers in Massachusetts. Read More
Read MoreHow to recruit diverse leadership for your company
Many companies are trying to diversity their leadership ranks. Here are some best practices and processes to increase the odds of success. Read More
Read MoreLightstone Ventures’ raises $375M for its largest fund yet
The Boston and Silicon Valley-based venture capital firm Lightstone Ventures has raised its third life sciences fund. Here’s what it plans to do with the money. Read More
Read MoreSmall-business owners could get billions in new proposal
The $25 billion SBA and small business package would be included in a much larger $3.5 trillion reconciliation bill. Read More
Read MoreIQHQ pitches more labs near Boston Landing
The four-building lab and office campus would span 354,000 square feet at 155 N. Beacon St. Read More
Read MoreACBJ expanding American Inno to all its local markets
American City Business Journals has significantly expanded its network of startup- and innovation-focused digital publications. Read More
Read MoreMeet Rhode Island Inno’s 2021 5 Under 25
They’re ambitious, they’re smart and they’re pretty darn successful. They’re also just starting out in their innovation careers. Meet Rhode Island Inno’s 2021 5 Under 25. Read More
Read MoreHere are BostInno’s 25 Under 25 for 2021
These are some of the brightest young minds in the Bay State right now. Read More
Read MoreBoston Children’s gets $20M donation for new pediatric heart center
A foundation overseen by a member of Boston Children’s Hospital’s trust board has given $20 million to the organization, one of the largest gifts in the institution’s history. Read More
Read MoreGoogle Ventures-incubated biotech raises $77M for drugs targeting ‘repeatome’
Armed with $77 million in new funding, Rome Therapeutics — the second-ever biotech company to be incubated by Google’s venture arm — is looking to double or even triple in the next two years as it develops a new pipeline of drugs. Read More
Read More